Department of Gastroenterology, Innlandet Hospital Trust, , Gjøvik, Oppland, Norway.
Gut. 2014 May;63(5):771-5. doi: 10.1136/gutjnl-2013-304766. Epub 2013 Jun 6.
Population-based studies have shown a slightly decreased life expectancy in patients with Crohn's disease (CD). The primary aim of the present study was to evaluate mortality and causes of death 20 years after the diagnosis in a well defined population-based cohort of CD patients in Norway.
The Inflammatory Bowel South-Eastern Norway study has prospectively followed all patients diagnosed with CD in the period between 1 January 1990 and 31 December 1993 in four geographically well-defined areas. All patients (n=237) were age and sex matched with 25 persons from the same county selected at random from the general population. Data on death and causes of deaths were collected from the Norwegian Causes of Death Register. All causes and cause-specific mortality (gastrointestinal cancer, cancer and heart disease) were modelled with Cox regression model stratified by matched sets. Results are expressed as HRs with 95% CIs.
There was no significant difference between CD patients and controls in overall mortality (HR=1.35, 95% CI 0.94 to 1.94, p=0.10). Furthermore, there were no marked differences in deaths from gastrointestinal cancer, other cancers or cardiovascular diseases in the CD group compared with the controls. In the CD group, 13.9% had died compared with 12.7% in the control group (p=0.578).
In our population-based inception cohort followed for 20 years, there was no increased mortality or more deaths from cancer compared with the general population.
基于人群的研究表明,克罗恩病(CD)患者的预期寿命略有下降。本研究的主要目的是评估在挪威一个明确的基于人群的 CD 患者队列中,诊断后 20 年的死亡率和死亡原因。
炎症性肠病南挪威研究前瞻性地随访了 1990 年 1 月 1 日至 1993 年 12 月 31 日期间在四个地理上明确界定的地区诊断为 CD 的所有患者。所有患者(n=237)按年龄和性别与同一县的随机选择的 25 名来自普通人群的个体相匹配。死亡和死因数据来自挪威死因登记处。使用 Cox 回归模型分层匹配组,对所有死因和死因特异性死亡率(胃肠道癌、癌症和心脏病)进行建模。结果表示为 HRs 和 95% CI。
CD 患者与对照组的总体死亡率无显著差异(HR=1.35,95%CI 0.94 至 1.94,p=0.10)。此外,与对照组相比,CD 组胃肠道癌、其他癌症或心血管疾病的死亡率没有明显差异。在 CD 组中,有 13.9%的患者死亡,而对照组中为 12.7%(p=0.578)。
在我们随访 20 年的基于人群的发病队列中,与普通人群相比,死亡率没有增加,癌症死亡也没有增加。